Document Detail

An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer.
Jump to Full Text
MedLine Citation:
PMID:  1562469     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CA-125 levels were assessed prior to each of the first three cycles of chemotherapy, in 81 patients with epithelial ovarian cancer receiving first-line chemotherapy. All patients have at least 1 year's follow-up. Thirty-nine patients (48%) have progressed clinically or have died within 1 year of treatment (treatment 'failures'). Three CA-125 indices previously shown to be of prognostic value are assessed for their ability to pick-out these 'failures'. When the indices examined are modified to obtain a specificity for picking out failures just exceeding 90%, the maximum sensitivity obtained was 46%. The use of CA-125 for clinical decision making in ovarian cancer requires further investigation to determine and validate a prognostic index with acceptable sensitivity and specificity, and to determine the clinical impact of treatment decisions made using such an index.
Authors:
D J Cruickshank; J Paul; C R Lewis; E J McAllister; S B Kaye
Related Documents :
12692659 - Meaning of illness and spirituality in ovarian cancer survivors.
19144189 - Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a ...
423159 - Total follicular populations in ewes of high and low ovulation rates.
9378149 - Prolonged remission of platinum-refractory ovarian cancer with docetaxel: brief report ...
2520799 - Ovarian metastasis from squamocellular cervical cancer, stages ib and iia.
3328119 - Galactosaemia.
8804469 - Carboplatin and etoposide in an out-patient schedule for the palliation of advanced non...
17906299 - Guidance on the use of bisphosphonates in solid tumours: recommendations of an internat...
23564799 - Influence of bacteriophage preparations on migration of hl-60 leukemia cells in vitro.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of cancer     Volume:  65     ISSN:  0007-0920     ISO Abbreviation:  Br. J. Cancer     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-05-19     Completed Date:  1992-05-19     Revised Date:  2010-09-07    
Medline Journal Info:
Nlm Unique ID:  0370635     Medline TA:  Br J Cancer     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  597-600     Citation Subset:  IM    
Affiliation:
Department of Obstetrics & Gynaecology, University of Aberdeen, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, Tumor-Associated, Carbohydrate / analysis*
Epithelium / pathology
Female
Humans
Ovarian Neoplasms / diagnosis*,  drug therapy,  immunology
Prognosis
Chemical
Reg. No./Substance:
0/Antigens, Tumor-Associated, Carbohydrate
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Br J Cancer
ISSN: 0007-0920
ISSN: 1532-1827
Article Information
Download PDF

Print publication date: Month: 4 Year: 1992
Volume: 65 Issue: 4
First Page: 597 Last Page: 600
ID: 1977546
PubMed Id: 1562469

An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer.
D. J. Cruickshank
J. Paul
C. R. Lewis
E. J. McAllister
S. B. Kaye
Department of Obstetrics & Gynaecology, University of Aberdeen, UK.



Article Categories:
  • Research Article


Previous Document:  Space-time clustering of childhood acute lymphoblastic leukaemia: indirect evidence for a transmissi...
Next Document:  Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in norm...